• email
  • rss
  • twitter
  • facebook
  • linkedin
  • News
  • Investors
  • Contact

Ceapro Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Quality Management System
    • Sustainability
  • Technologies
    • Overview
    • Ethanol Fractionation Processes
    • Pressurized Gas Expanded (PGX) Technology
    • Chromatography Purification
    • Intellectual Property
    • Scientific Publications
  • Pipeline
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
    • Product Brochures
  • Cosmeceuticals
    • Overview
  • Nutraceuticals
    • Overview
    • Oat Beta Glucan
    • Avenanthramides
  • Business Development
    • Overview
    • Partners
  • News
  • Investors
  • Contact
  • Home
  • Investors
  • News / Events
  • Press Releases
Navigation
  • Overview
  • News / Events
    • Press Releases
    • Events
    • Email Alerts
  • Company Information
  • Financial Information
  • Stock Data
  • Corporate Governance
  • SEDAR
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007

Ceapro Inc. Reports 2020 Second Quarter and Six-Month Financial Results and Operational Highlights

August 20, 2020

Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic for COVID-19

August 18, 2020

Ceapro Inc. Announces Publication of Positive Results from Study Evaluating Avenanthramides in Exercise-Induced Inflammation

August 4, 2020

Ceapro Announces Results of 2020 Shareholders’ Meeting

June 22, 2020

Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing

June 15, 2020

Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series

June 9, 2020

Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights

May 28, 2020

Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19

May 26, 2020

Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights

April 16, 2020

Ceapro Inc. to Present at the April 2020 Virtual Investor Summit

April 15, 2020

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...24
  • Next »

Sign up for email ALERTS Be the first to receive news and updates on Ceapro. Sign Up

  • © 2023 Ceapro Inc.
  • Privacy Policy
  • Disclaimer
  • Sitemap